• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

4.180 -0.100 (-2.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
December 28, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
December 21, 2023
New System Saves Time and Resources, Improves Efficiency and Accuracy 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Says ↗
December 14, 2023
Stephens initiated coverage on Cytek Biosciences Inc (NASDAQ: CTKB), a manufacturer and supplier of flow cytometry products and services.  
Via Benzinga
Topics Supply Chain
News headline image
The Latest Analyst Ratings for Cytek Biosciences ↗
December 14, 2023
 
Via Benzinga
News headline image
Why Shares of Cytek Biosciences Dropped This Week ↗
May 12, 2023
Cytek grew revenue and losses in the first quarter. 
Via The Motley Fool
News headline image
Where Cytek Biosciences Stands With Analysts ↗
May 10, 2023
 
Via Benzinga
News headline image
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
November 08, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
November 08, 2023
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
November 07, 2023
 
Via Benzinga
News headline image
Cytek Biosciences Reports Third Quarter 2023 Financial Results
November 07, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Morgan Stanley Maintains Equal-Weight Rating for Cytek Biosciences: Here's What You Need To Know ↗
October 24, 2023
 
Via Benzinga
News headline image
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
October 19, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
October 17, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. 
Via Benzinga
News headline image
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday ↗
October 17, 2023
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
September 27, 2023
Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
September 20, 2023
Company to Lead Symposiums at ICCS and ESCCA 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
September 14, 2023
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
August 28, 2023
Sales Organization Enhanced, Platform Organization Created 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
August 10, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports Second Quarter 2023 Financial Results
August 08, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
July 20, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
May 31, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Announces $50 Million Stock Repurchase Program
May 19, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023 ↗
July 19, 2023
 
Via Benzinga
News headline image
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
May 16, 2023
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
May 10, 2023
 
Via Benzinga
News headline image
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap